Deep Dive into Metabolomics
Learn more about our comprehensive, deep dive metabolomics platform
HMT Webinar Series: Host-Microbiota Communications
Join Dr. Alexander Buko as he discusses novel technologies for understanding metabolomic communications between host and microbiota
Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, released an analysis service offering cancer metabolism profiling, CARCINOSCOPE.
A Brief Introduction to HMT
Human Metabolome Technologies (HMT) is a Japan-based biotechnology company developing capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solution to drive drug discovery, diagnosis, and food production. Our research and development methodology are at the heart of an emerging field of metabolomics and systems biology.
F-SCOPE, a quantitative 13C/15N labeling analysis, provides a unique snapshot of metabolic changes in your research setting.
Learn more about HMT and our Technology
HMT America Members discuss what makes HMT so unique
HMT Webinar Series: Isotope Analyses
Isotope Analyses – Modeling the Ever-Changing Metabolomic Landscape